{Reference Type}: Journal Article
{Title}: Primary nasopharyngeal carcinoma with cerebrospinal fluid EBV positivity: A case report and mini literature review.
{Author}: Feng J;Wang S;Zhang H;Zhao J;Wang X;
{Journal}: Infect Med (Beijing)
{Volume}: 3
{Issue}: 1
{Year}: 2024 Mar
暂无{DOI}: 10.1016/j.imj.2024.100089
{Abstract}: <B>UNASSIGNED: </B>To summarize the diagnosis and treatment of a patient with nasopharyngeal carcinoma and cerebrospinal fluid (CSF) Epstein-Barr virus (EBV) positivity (determined by next-generation sequencing), review the relevant literature, and explore the significance of EBV presence in the CSF of patients with nasopharyngeal carcinoma.<BR><B>UNASSIGNED: </B>A patient presenting with headache as the initial symptom was diagnosed with nasopharyngeal carcinoma and admitted to the Eighth Medical Center of Chinese PLA General Hospital on March 3, 2021. Available databases were screened for reports on nasopharyngeal carcinoma with EBV-positive CSF and analyzed. The patients' general information, initial symptoms, treatment, and prognosis were subsequently evaluated.<BR><B>UNASSIGNED: </B>EBV-positive CSF is commonly observed in patients with recurrent nasopharyngeal carcinoma. However, no reports of EBV-positive CSF in patients with primary nasopharyngeal carcinoma have been published to date.<BR><B>UNASSIGNED: </B>The presence of EBV in the CSF of patients with recurrent nasopharyngeal carcinoma is indicative of a poor prognosis. Thus, newly diagnosed nasopharyngeal carcinoma patients should undergo a lumbar puncture as soon as possible to have their CSF tested for EBV. Such a measure would promptly predict the prognosis and facilitate the development of a personalized treatment strategy.